title: Oxygen free radical producing leukocytes cause functional depression of isolated rat hearts: role of leukotrienes.
abstract: Polymorphonuclear granulocytes PMN) are suggested mediators of myocardial ischemia-reperfusion injury. We have previously shown that activated PMN producing oxygen free radicals (OFR) in the coronary circulation are cardiodepressive. OFR may induce lipid peroxidation and production of eicosanoids. We have investigated the influence of cyclo-oxygenase and lipoxygenase inhibitors on the effects of activated, OFR producing PMN in the Langedorff rat heart model. Left ventricular developed pressure (LVDP) was measured by a balloon in the left ventricle. Human PMN and drugs were given into the aortic cannula for 10 min and the hearts were observed for 30 min thereafter. After infusion for 5 min OFR production in the cellular infusate was measured at the level of the aortic cannula by a chemiluminescence (CL) technique. Phorbol 12-myristate 13-acetate (PMA)-activated PMN (n = 8), produced a CL response of 27649 +/- 11048 counts (mean +/- S.E.M.), and reduced coronary flow (CF) to 53 +/- 6% (mean +/- S.E.M.) and LVDP to 38 +/- 9% of baseline values at the end of the observation period. Ibuprofen (n = 6), a cyclooxygenase (CO) inhibitor, neither influenced the CL response (31915 +/- 7563) of activated PMN, nor the reduction of CF and LVDP at this time. Although both BW 755C (n = 7), a dual inhibitor of CO and lipoxygenase (LO) (CF:90 +/- 4%, LVDP:99 +/- 6%) and diethylcarbamazine (DCM) (n = 8), a LO inhibitor (CF:88 +/- 11%, LVDP:87 +/- 4%), significantly inhibited the cardiodepressive effects of activated PMN. BW 755C alone abolished the CL response (431 +/- 158 counts), whereas DCM had no effect on CL (30105 +/- 1698 counts).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Physiology and Surgery, University of Tromsø, Norway.
authors.forename: A G
authors.initials: AG
authors.lastname: Semb
authors.forename: J
authors.initials: J
authors.lastname: Vaage
authors.forename: O D
authors.initials: OD
authors.lastname: Mjøs
mesh_terms: D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine / Q000494:pharmacology; D000818:Animals; D001783:Blood Flow Velocity / Q000502:physiology; D001794:Blood Pressure / Q000502:physiology; D016861:Cyclooxygenase Inhibitors; D004049:Diethylcarbamazine / Q000494:pharmacology; D005609:Free Radicals; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate / Q000502:physiology; D007052:Ibuprofen / Q000494:pharmacology; D007962:Leukocytes / Q000378:metabolism* / Q000502:physiology; D015289:Leukotrienes / Q000502:physiology; D016859:Lipoxygenase Inhibitors; D008163:Luminescent Measurements; D008297:Male; D010100:Oxygen / Q000378:metabolism* / Q000494:pharmacology / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D016861:Cyclooxygenase Inhibitors; D005609:Free Radicals; D015289:Leukotrienes; D016859:Lipoxygenase Inhibitors; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D010100:Oxygen; D004049:Diethylcarbamazine; D007052:Ibuprofen